Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575
Beginning balance	$ (1,035,129)	$ (931,279)
Net loss	$ (118,473)	$ (103,850)
Ending balance (in shares)	1,899,575	1,899,575
Ending balance	$ (1,153,602)	$ (1,035,129)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,455,713)	(9,351,863)
Net loss	(118,473)	(103,850)
Ending balance	$ (9,574,186)	$ (9,455,713)